Outcomes Associated With Anti‐Depressant Use in Patients With Inflammatory Bowel Disease
Antidepressant use is associated with reduced ER utilisation in patients with IBD. There were also increased hospitalisations, corticosteroid treatment, and surgery, which may reflect a more aggressive disease course associated with depression. Treating depression in patients with IBD may reduce healthcare costs by decreasing ER visits.
Authors
- Bharati D. Kochar (ORCID: https://orcid.org/0000-0002-8862-1236)
- Lara Chaaban (ORCID: https://orcid.org/0000-0003-1294-8790)
- Prasanna Challa
- Alexandra Fuss (ORCID: https://orcid.org/0009-0005-5794-7291)
- Joanna Melia (ORCID: https://orcid.org/0000-0002-0984-4600)
- Ashwin N. Ananthakrishnan (ORCID: https://orcid.org/0000-0002-9436-1821)
- Lynn Kobeissi (ORCID: https://orcid.org/0009-0006-7874-6314)
Institutions
- Boston Biomedical Research Institute (US)
- Harvard University (US)
- Johns Hopkins University (US)
- Massachusetts General Hospital (US)
- Johns Hopkins Hospital (US)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2025-06-07
- DOI
- https://doi.org/10.1111/apt.70229
- Citations
- 3
- Primary Topic
- Adolescent and Pediatric Healthcare
- Type
- article
- Field-Weighted Citation Impact
- 9.35
Funders
- National Institute on Aging